Cite
HARVARD Citation
Gujrati, M. et al. (2016). Cancer Therapy: Targeted Dual pH‐Sensitive Lipid ECO/siRNA Self‐Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy (Adv. Healthcare Mater. 22/2016). Advanced healthcare materials. 5 (22), p. 2836. [Online].